SCHEMBL25908970

SCHEMBL25908970

CN(C=S)C(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.48
RECQL P46063 1/20 0.47
ALDH1A1 P00352 4/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 2/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
HSP90AA1 P07900 2/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
DAO P14920 1/20 0.42
TSHR P16473 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
MEN1 O00255 1/20 0.42
HSP90AB1 P08238 1/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10336149 0.84 HSD11B1 (0.50) HSD11B1RECQLALDH1A1HPGDRAB9A
SCHEMBL7534584 0.83 HSD11B1 (0.48) HSD11B1RECQLALDH1A1HPGDRAB9A
SCHEMBL6317037 0.83 HSD11B1 (0.48) HSD11B1RECQLALDH1A1HPGDRAB9A
SCHEMBL4585829 0.81 HSD11B1 (0.47) HSD11B1RECQLALDH1A1MAPTHPGD
SCHEMBL2134534 0.81 AKT1 (0.48) HSD11B1RECQLALDH1A1HPGDRAB9A
SCHEMBL14855368 0.81 HSD11B1 (0.47) HSD11B1RECQLALDH1A1HPGDRAB9A
SCHEMBL18131923 0.79 RECQL (0.48) HSD11B1RECQLALDH1A1HPGDRAB9A
SCHEMBL10426607 0.78 ALDH1A1 (0.44) HSD11B1RECQLALDH1A1MAPTHPGD
SCHEMBL14247670 0.78 RECQL (0.52) HSD11B1RECQLALDH1A1MAPTHPGD
SCHEMBL5552448 0.78 KDM4E (0.46) HSD11B1RECQLALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242552-A1 Nitrogen-Containing Heterocyclic Compound, Preparation Method Therefor and Use Thereof 280 Bio, Inc (US) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242552-A1 Nitrogen-Containing Heterocyclic Compound, Preparation Method Therefor and Use Thereof NRAS, KRAS, RAB8A HSD11B1 229/4885RECQL 3158/4885ALDH1A1 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.